Wenlang Fu
10Patents
3h-index
62Co-inventors
59Inventor score
Filing activity: Oct 8, 2004 → May 26, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8877439B2 | Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications | Chemistry; Metallurgy | 19 | Active |
| US7563791B2 | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | Chemistry; Metallurgy | 8 | Expired |
| US7582645B2 | Pyrimidine derivatives for treatment of hyperproliferative disorders | Chemistry; Metallurgy | 3 | Expired |
| US7678804B2 | Pyrimidine derivatives for treatment of hyperproliferative disorders | Chemistry; Metallurgy | 3 | Active |
| US10450335B2 | Antiviral oxime phosphoramide compounds | Human Necessities | 3 | Active |
| US9512426B2 | Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications | Chemistry; Metallurgy | 2 | Active |
| US9040691B2 | Hydroxymethylaryl-substituted pyrrolotriazines as ALK1 inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8338595B2 | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | Chemistry; Metallurgy | 0 | Active |
| US12304899B2 | Factor XI activation inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7582646B2 | Pyrimidine derivatives for treatment of hyperproliferative disorders | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.